XML 33 R11.htm IDEA: XBRL DOCUMENT v3.23.1
LIQUIDITY AND GOING CONCERN
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
LIQUIDITY AND GOING CONCERN LIQUIDITY AND GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. As of December 31, 2022, the Company has unrestricted cash and cash equivalents of approximately $12.6 million. In March 2023, the Company received net proceeds of approximately $4.4 million from the closing of a registered direct offering further described in Note 12—Subsequent Events. Without additional sources of funding, the Company’s unrestricted cash and cash equivalents at December 31, 2022, combined with the net proceeds from the March 2023 Offering, are not sufficient for the Company to continue as a going concern for a period of at least one year from the date of filing this Annual Report on Form 10-K. The Company expects to incur substantial losses in the future as it progresses its current product pipeline, seeks regulatory approval for product candidates and prepares for commercialization.Based on the Company’s limited operating history, recurring negative cash flows from operations, current plans and available resources, the Company will need substantial additional funding to support future operating activities. The Company has concluded that the prevailing conditions and ongoing liquidity risks faced by the Company raise substantial doubt about the Company’s ability to continue as a going concern for at least one year following the date these financial statements are issued. The accompanying consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.The Company may seek to raise additional funding through dilutive and non-dilutive financings. There can be no assurance that the Company will be able to obtain additional capital on terms acceptable to the Company, on a timely basis or at all. The failure to obtain sufficient additional funding could adversely affect the Company’s ability to achieve its business objectives and product development timelines and could have a material adverse effect on the Company’s results of operations.